Entera Bio to Present at the H.C. Wainwright 22nd Annual Global Investment Conference. BOSTON and JERUSALEM, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate virtually in the H.C. Wainwright Global Investment Conference on Tuesday, September 15, 2020 at 3:00 p.m. EDT.



To access a live webcast of the fireside chat on the “Investor Relations” page of Entera’s website, please click here . A replay of the webcast will be archived on Entera’s website for approximately 45 days following the presentation.

About Entera Bio